Advertisement

Topics

Roche acquires GeneWEAVE to strengthen offerings in microbiology diagnostics

01:00 EDT 13 Aug 2015 | Hoffmann-La Roche Ltd

Roche today announced that it has signed a definitive agreement to acquire GeneWEAVE BioSciences, Inc. (GeneWEAVE), a privately held company focused on innovative, clinical microbiology diagnostics solutions based in Los Gatos, CA, USA. Under the terms of the agreement, Roche will pay GeneWEAVE shareholders USD 190 million upfront and up to USD 235 million in contingent product related milestones.

Original Article: Roche acquires GeneWEAVE to strengthen offerings in microbiology diagnostics

NEXT ARTICLE

More From BioPortfolio on "Roche acquires GeneWEAVE to strengthen offerings in microbiology diagnostics"

Advertisement
Quick Search
Advertisement
Advertisement